Volume : 09, Issue : 07, July – 2022
Title:
57.FORMULATION AND EVALUATION OF MICROSPONGES LOADED WITH ANTI-INFLAMMATORY DRUG SULFASALAZINE
Authors :
K. Naga Jyothi*, Dr. P. Dinesh Kumar
Abstract :
The present research is aimed to develop and characterize Sulfasalazine loaded microsponges-based novel colon-specific drug delivery systems in a view to bypass the upper gastrointestinal tract (GIT) for enhanced therapeutic effect. Microsponges were developed by quasi emulsion solvent diffusion method by using two different polymers Eudragit L-100 and Ethyl cellulose in the ratio of 1:1, 1:0.75, 1:0.5,1:0.25. Among these formulations two were selected, sieved and compressed into tablets. Then tablets were evaluated. The F4 was selected as optimized formulation based on % entrapment efficiency of 94.56%, and % cumulative drug release of 94.76. Release studies revealed that microsponges prevented the premature release of Sulfasalazine in upper GIT and specifically released the drug at colonic pH.
Key words: Microsponges, Inflammatory bowel disease, colon.
Cite This Article:
Please cite this article in press Korrapati Jyothi et al, Formulation And Evaluation Of Microsponges Loaded With Anti-Inflammatory Drug Sulfasalazine., Indo Am. J. P. Sci, 2022; 09(7).,
Number of Downloads : 10
References:
1. Barbara L, Teresa C, Federica B, Isabella O, Vittorio Z: pH-sensitive polymeric physical-mixture for possible sitespecific delivery of ibuprofen. Eur J Pharm Biopharm 2003; 55: 199-202.
2. Lachman L, Lieberman HA, Kanig JL: The theory and practice of industrial pharmacy. 3rd edition. Bombay, Varghese publishing house: Hind Rajasthan building; 1991. p. 293.
3. Antonin KH, Rak R, Beick PR, Schenker U, Hastewell J, Fox R: The absorption of human calcitonin from the transverse colon of man. Int J Pharm. 1996;130: 33-39.
4. Karthika.R., Elango.K., Ramesh Kumar K., Rahul.K. Formulation and evaluation of lornoxicammicrosponge tablets for the treatment of arthritis. Int. J. Pharmaceutical innovations. 2013; 3(2):29-40.
5. Kruis W, Bar-Meir S, Feher J, Mickisch O, Mlitz H, Faszczyk M. The optimal dose of 5 aminosalicylic acid in active ulcerative colitis: a dose-finding study with newly developed mesalamine. Clin Gastroenterol Hepatol 2003;31;1:36-4.
6. Sinha VR, Kumria R. Coating polymers for colon specific drug delivery: a comparative in vitro evaluation. Acta Pharm 2003;53:41-7.
7. Sonali, Rahul Pratap Singh and Sunil Kumar Prajapati, Formulation and Evaluation of Prednisolone loaded Microsponges for Colon Drug Delivery: In-Vitro And Pharmacokinetic Study, IJPSR (2014), Vol. 5, Issue 5.
8. Yasir Mehmood, Application of UV spectrophotometric method for easy and rapid estimation of sulfasalazine in pharmaceutical formulation, Pharm Methods, 2017.
9. S. Janakidevi* And K. V. Ramanamurthy, development of colon-targeted microsponges for the treatment of inflammatory bowel disease, Indian Journal of Pharmaceutical Sciences, July-August 2018.
10. Sareen R, Nath K, Jain N, Dhar KL. Curcumin loaded microsponges for colon targeting in inflammatory bowel disease: Fabrication, optimization, and in vitro and pharmacodynamic evaluation. Biomed Res Int 2014;340701.
11. Jain V, Singh R. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges. Arch Pharm Res 2011;34:733-40.
12. Jelvehgari M, Siahi-Shadbad MR, Azarmi S, Martin GP, Nokhodchi A. The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies. Int J Pharm 2006;308:124-32.
13. Devrim B, Canefe K. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi emulsion Solvent diffusion method: effect of variables. Acta Pol Pharm 2006;63:521-34.
14. Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm 2006;318:103-17.
15. Kumari A, Jain A, Hurkat P, Tiwari A, Jain SK, Eudragit S100 coated microsponges for Colon targeting of prednisolone, Drug Development and Industrial Pharmacy,Volume 44,2018.